While Cellebrite DI Ltd has underperformed by -0.78%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CLBT rose by 121.85%, with highs and lows ranging from $17.82 to $6.36, whereas the simple moving average jumped by 38.26% in the last 200 days.
On March 28, 2024, Needham Reiterated Cellebrite DI Ltd (NASDAQ: CLBT) to Buy. A report published by William Blair on March 13, 2024, Upgraded its rating to ‘Outperform’ for CLBT. BofA Securities also Upgraded CLBT shares as ‘Buy’, setting a target price of $12 on the company’s shares in a report dated February 16, 2024. Craig Hallum Initiated an Buy rating on July 19, 2023, and assigned a price target of $11. William Blair August 12, 2022d its ‘Outperform’ rating to ‘Mkt Perform’ for CLBT, as published in its report on August 12, 2022. BofA Securities’s report from August 12, 2022 suggests a price prediction of $6 for CLBT shares, giving the stock a ‘Neutral’ rating. JP Morgan also rated the stock as ‘Overweight’.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Analysis of Cellebrite DI Ltd (CLBT)
Further, the quarter-over-quarter increase in sales is 24.82%, showing a positive trend in the upcoming months.
Cellebrite DI Ltd’s future performance can be predicted by a variety of well-rounded types of analysis and research, with equity being one of the most crucial ones. The goal here is to ensure that your current return on equity of -1768.51% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.69, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can be an extremely valuable indicator of volatility, and CLBT is registering an average volume of 1.38M. On a monthly basis, the volatility of the stock is set at 3.15%, whereas on a weekly basis, it is put at 3.31%, with a loss of -3.86% over the past seven days. Furthermore, long-term investors anticipate a median target price of $19.14, showing growth from the present price of $16.55, which can serve as yet another indication of whether CLBT is worth investing in or should be passed over.
How Do You Analyze Cellebrite DI Ltd Shares?
Besides checking the fundamentals, you should also know how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 70.54%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 33.49% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
CLBT shares are owned by institutional investors to the tune of 33.49% at present.
